Lanean...

Intraprostatic Botulinum Toxin injection in patients with benign prostatic enlargement

Histological evidence of benign prostatic hyperplasia (BPH) exceeded 50% in men over 50 years of age and rose to 75% as men entered the eighth decade. Therapeutic options for BPH generally fall into one of the three categories: watchful waiting, medical treatment and surgery. Excluding watchful wait...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Ilie, CP, Chancellor, MB, Chuang, YC, Mischianu, D
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Carol Davila University Press 2009
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3019017/
https://ncbi.nlm.nih.gov/pubmed/20108746
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!